Retinal Degeneration 3 (RD3) (N-Term) Peptid
RD3
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle RD3 Produkte
- RD3 (Retinal Degeneration 3 (RD3))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-RD3 antibody (Catalog #: ARP55856_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- RD3 (Retinal Degeneration 3 (RD3))
- Hintergrund
-
RD3 is preferentially expressed in retina.Defects in RD3 are the cause of Leber congenital amaurosis type 12 (LCA12).
Alias Symbols: C1orf36, LCA12
Protein Size: 195 - Molekulargewicht
- 23 kDa
- Gen-ID
- 343035
- NCBI Accession
- NM_183059, NP_898882
- UniProt
- Q7Z3Z2
-
Sie sind hier:
